We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be th... Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition. Show more
Elevation Oncology to Present at the Citizens JMP Life Sciences Conference PR Newswire BOSTON, May 7, 2024 BOSTON, May 7, 2024 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an...
Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements PR Newswire BOSTON, May 2, 2024 -- Enrollment ongoing in Phase 1 clinical trial of...
Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024 PR Newswire BOSTON, April 8, 2024 -- On-track to nominate development candidate in...
Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements PR Newswire BOSTON, March 6, 2024 --Expanded ongoing Phase 1 clinical...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.36 | 9.83606557377 | 3.66 | 4.33 | 3.565 | 557892 | 3.89145885 | CS |
4 | 0.21 | 5.51181102362 | 3.81 | 4.33 | 3.28 | 402748 | 3.68532244 | CS |
12 | -0.56 | -12.2270742358 | 4.58 | 5.8299 | 3.1801 | 740635 | 4.2863811 | CS |
26 | 3.5245 | 711.301715439 | 0.4955 | 5.8299 | 0.4401 | 1827904 | 2.70282885 | CS |
52 | -0.43 | -9.66292134831 | 4.45 | 5.8299 | 0.363 | 1107451 | 2.49218365 | CS |
156 | -9.98 | -71.2857142857 | 14 | 16.22 | 0.363 | 634722 | 3.07453115 | CS |
260 | -9.98 | -71.2857142857 | 14 | 16.22 | 0.363 | 634722 | 3.07453115 | CS |
Symbol | Price | Vol. |
---|---|---|
NVOSNovo Integrated Sciences Inc | $ 1.05 (132.82%) | 310.28M |
GWAVGreenwave Technology Solutions Inc | $ 0.0387 (-7.86%) | 305.13M |
FFIEFaraday Future Intelligent Electric Inc | $ 0.584899 (3.47%) | 223.84M |
SQQQProShares UltraPro Short QQQ | $ 10.02 (0.00%) | 161.89M |
CRKNCrown Electrokinetics Corporation | $ 0.0998 (-12.07%) | 155.13M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions